Table 2 Relationship between HOS and clinical-pathological features
From: Risk factors for developing high-output ileostomy in CRC patients: a retrospective study
Clinicopathological | Cases | Indicators HOS n (%) | P value |
|---|---|---|---|
Gender | 0.741 | ||
Male | 271 | 61 (22.5) | |
Female | 223 | 53 (23.8) | |
Age | 0.537 | ||
> 60 years old | 193 | 44 (22.8) | |
≤ 60 years old | 291 | 70 (24.1) | |
Gross type | 0.726 | ||
Massive type | 219 | 53 (24.2) | |
Ulcerative type | 162 | 38 (23.5) | |
Infiltrating type | 113 | 23 (20.4) | |
Organizational grading | 0.197 | ||
Highly differentiated | 178 | 36 (20.2) | |
Medium differentiation | 191 | 42 (22.0) | |
Poorly differentiated | 125 | 36 (28.8) | |
Tumor site | 0.487 | ||
Rectum | 351 | 79 (22.5) | |
Colon | 143 | 35 (24.5) | |
Lymph node metastasis | 0.487 | ||
Yes | 307 | 74 (24.1) | |
No | 187 | 40 (21.4) | |
TNM staging | 0.934 | ||
Phase I | 55 | 13 (23.6) | |
Phase II | 85 | 20 (23.5) | |
Phase III | 229 | 50 (21.8) | |
Phase IV | 125 | 31 (24.8) | |